The Double Marker Test is a vital prenatal screening test designed to detect chromosomal abnormalities in the fetus, such as Down Syndrome and Edward Syndrome. Conducted during the first trimester, this test evaluates hormone levels in the mother's blood, including free beta-hCG and PAPP-A, to assess the risk of genetic conditions. It is non-invasive, safe, and provides critical insights into the baby’s health, enabling timely medical intervention if needed. Expectant parents are encouraged to discuss this test with their healthcare provider to ensure a healthy pregnancy journey.